Skip to content

Research on the construction and clinical translation of precision treatment system for benign prostatic hyperplasia disease

Research on the construction and clinical translation of precision treatment system for benign prostatic hyperplasia disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036552
Enrollment
Unknown
Registered
2020-08-24
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

6-point tunneling method:6-point tunneling method
tri-lobe enucleation:tri-lobe enucleation

Sponsors

Ninth People's Hospital, School of Medicine Shanghai Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients who are diagnosed as BPH by CT or MRI and have symptoms of LUTS; 2. Those who have not received surgical treatment after BPH is discovered; 3. The life expectancy of the patient is greater than 3 years; 4. I or the client agree to join this research, sign an informed consent form, and voluntarily provide relevant personal information and tissue samples for this research.

Exclusion criteria

Exclusion criteria: 1. Patients whose clinical diagnosis or biopsy is confirmed as prostate tumor; 2. Patients who have a history of surgery that affects the prognosis assessment; 3. Patients with other symptoms that can affect the evaluation of prostate hyperplasia; 4. Patients who cannot or refuse surgery, so that they cannot obtain pathological results; 5. Refusing to accept the relevant treatment plan or follow-up plan.

Design outcomes

Primary

MeasureTime frame
IPSS;

Secondary

MeasureTime frame
QoL;Qmax;PVR;

Countries

China

Contacts

Public ContactZhongwang

The Ninth People's Hospital, School of Medicine Shanghai Jiaotong University

zhongwang2010@sina.com+86 13301980998

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026